Bionter Ag Secures $3 Million In Series Seed Financing Led By Dynamk Capital
04/27/22, 2:19 AM
Location
riehen
Money raised
$3 million
Round Type
seed
Bionter AG, experts in sub-visible particle testing, announced the completion of a $3 million Series Seed financing from Dynamk Capital. Bionter revolutionizes analytical testing of subvisible particles in the biopharmaceutical industry in respect to economy, process time and safety.
Company Info
Location
riehen, basel-stadt, switzerland
Additional Info
Bionter (www.bionter.com) is a recently founded Switzerland based company with the purpose of revolutionizing analytical testing for the benefit of people's health. Bionter is driving patient safety, cost efficiency and sustainability through disruptive innovations in particle testing that are increasing the quality of drug product testing. Bionter`s first product is a particle counter that is not only fully automated but also allows non-destructive sample testing.